The interbody fusion device is designed for the cervical spine with integrated fixation. It uses Titan’s proprietary surface technology that participates in the fusion process by creating an osteogenic response to the implant’s topography.
Paul Slosar, MD, performed the first surgery using the Endoskeleton TCS on Feb. 9 at Saint Francis Memorial Hospital in San Francisco. The device is the 7th interbody device in Titan’s portfolio of titanium spinal implant products.
More articles on devices:
7 key trends in joint replacement customization
Amedica files FDA application for spinal implant spacers with porous silicon nitride center — 6 things to know
Revenue up, $147k net loss — 10 key points on RTI Surgical’s 2014 financial report
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
